Sales & Marketing ADHD medication scarcity adds to questions on US supply chai... Ben Hargreaves looks into why ADHD medicines are still suffering shortages nearly a year after first being announced.
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.